Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  dexverapamil
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-6 of 6 for your search:
Start Over
Phase I/II Study of R-VPAM/DOX for Recurrent Sarcomas (Summary Last Modified 09/95)
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: any age
Sponsor: NCI
Protocol IDs: CCF-IRB-1105, NCI-T94-0167D, T94-0167
Phase II Study of Paclitaxel with the Multidrug Resistance Modulator Dexverapamil for Metastatic Breast Cancer (Summary Last Modified 06/95)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: TCINJ-940-1529, NCI-T94-0122O, T94-0122
Phase II Study of VBL with Dexverapamil for Metastatic Renal Cell Cancer (Summary Last Modified 01/95)
Phase: Phase II
Type: Treatment
Status: Completed
Age: over 18
Sponsor:
Protocol IDs: MSKCC-91120, NCI-V92-0024
Phase II Pilot Study of Continuous-Infusion VIDA (VP-16/IDA/ARA-C) with or without R-Verapamil in Patients with Secondary AML or DeNovo AML in Relapse (Summary Last Modified 06/93)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-92-C-0241, NCI-MB-296, NCI-T92-0085N, T92-0085
Phase I Study of TAX with R-VPAM and G-CSF in Patients with Previously Treated, Metastatic Breast Cancer (Summary Last Modified 11/94)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-92-C-0245K, NCI-MB-301, NCI-T92-0118N, T92-0118
Start Over